Affordable Insulin for the COVID–19 Emergency Act
A BILL
To amend title XVIII of the Social Security Act to eliminate cost-sharing with respect to coverage of insulin as a covered part D drug and associated medical supplies and to provide mail order access to insulin and such supplies under the Medicare program during the COVID–19 emergency period.
2. Eliminating cost-sharing with respect to coverage of insulin as a covered part D drug and associated medical supplies under the Medicare program during the COVID–19 emergency period
“(8) Elimination of cost-sharing for insulin and associated medical supplies during the COVID–19 emergency period—The coverage does not impose any deductible, copayment, coinsurance, or other cost-sharing for insulin (as described in subparagraph (B) of subsection (e)(1)) or medical supplies associated with the injection of insulin (as described in such subparagraph) during the emergency period described in section 1135(g)(1)(B).”
“(4) Same elimination of cost-sharing for certain covered part D drugs during the COVID–19 emergency period—The coverage is in accordance with subsection (b)(8).”
“(F) Elimination of cost-sharing for certain covered part d drugs during the COVID–19 emergency period—Coverage that is in accordance with section 1860D–2(b)(8).”
“(F) Elimination of cost-sharing for certain covered part D drugs during the COVID–19 emergency period—Coverage that is in accordance with section 1860D–2(b)(8).”
3. Mail order access of insulin and associated medical supplies under the Medicare program during the COVID–19 emergency period
“(C) Mail order—A prescription drug plan or MA–PD plan shall permit such part D eligible individual enrolled in such plan to obtain such fill or refill of insulin (as described in subparagraph (B) of section 1860D–2(e)(1)) or medical supplies associated with the injection of insulin (as described in such subparagraph), at the option of such individual, by mail order to the home of such individual.”